Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Downgrades Comerica to Neutral, Lowers Price Target to $59

Author: Benzinga Newsdesk | April 04, 2024 03:02pm
UBS analyst Erika Najarian downgrades Comerica (NYSE:CMA) from Buy to Neutral and lowers the price target from $66 to $59.

Posted In: CMA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist